192 related articles for article (PubMed ID: 7462703)
1. Emergence of multiply antibiotic-resistant Vibrio cholerae in Bangladesh.
Glass RI; Huq I; Alim AR; Yunus M
J Infect Dis; 1980 Dec; 142(6):939-42. PubMed ID: 7462703
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of antimicrobial resistant cholera in Kenya and East Africa.
Finch MJ; Morris JG; Kaviti J; Kagwanja W; Levine MM
Am J Trop Med Hyg; 1988 Nov; 39(5):484-90. PubMed ID: 3195696
[TBL] [Abstract][Full Text] [Related]
3. Plasmid-borne multiple drug resistance in Vibrio cholerae serogroup O1, biotype El Tor: evidence for a point-source outbreak in Bangladesh.
Glass RI; Huq MI; Lee JV; Threlfall EJ; Khan MR; Alim AR; Rowe B; Gross RJ
J Infect Dis; 1983 Feb; 147(2):204-9. PubMed ID: 6827137
[TBL] [Abstract][Full Text] [Related]
4. Diversity of Vibrio cholerae strains isolated in Delhi, India, during 1992-2000.
Das S; Gupta S
J Health Popul Nutr; 2005 Mar; 23(1):44-51. PubMed ID: 15884751
[TBL] [Abstract][Full Text] [Related]
5. Emergence of tetracycline resistance due to a multiple drug resistance plasmid in Vibrio cholerae O139.
Yamamoto T; Nair GB; Takeda Y
FEMS Immunol Med Microbiol; 1995 Apr; 11(2):131-6. PubMed ID: 7640673
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and genetic characterization of Vibrio cholerae O1 isolated from various regions of Kenya between 2007 and 2010.
Mercy N; Mohamed AA; Zipporah N; Chowdhury G; Pazhani GP; Ramamurthy T; Boga HI; Kariuki SM; Joseph O
Pan Afr Med J; 2014; 19():8. PubMed ID: 25584121
[TBL] [Abstract][Full Text] [Related]
7. Clinical features, antimicrobial susceptibility and toxin production in Vibrio cholerae O139 infection: comparison with V. cholerae O1 infection.
Dhar U; Bennish ML; Khan WA; Seas C; Huq Khan E; Albert MJ; Abdus Salam M
Trans R Soc Trop Med Hyg; 1996; 90(4):402-5. PubMed ID: 8882188
[TBL] [Abstract][Full Text] [Related]
8. Characterization and Genetic Variation of Vibrio cholerae Isolated from Clinical and Environmental Sources in Thailand.
Siriphap A; Leekitcharoenphon P; Kaas RS; Theethakaew C; Aarestrup FM; Sutheinkul O; Hendriksen RS
PLoS One; 2017; 12(1):e0169324. PubMed ID: 28103259
[TBL] [Abstract][Full Text] [Related]
9. Antibiotics resistance in El Tor Vibrio cholerae 01 isolated during cholera outbreaks in Mozambique from 2012 to 2015.
Dengo-Baloi LC; Semá-Baltazar CA; Manhique LV; Chitio JE; Inguane DL; Langa JP
PLoS One; 2017; 12(8):e0181496. PubMed ID: 28792540
[TBL] [Abstract][Full Text] [Related]
10. Changing Susceptibility Pattern of
Parvin I; Shahunja KM; Khan SH; Alam T; Shahrin L; Ackhter MM; Sarmin M; Dash S; Rahman MW; Shahid ASMSB; Golam Faruque AS; Ahmed T; Chisti MJ
Am J Trop Med Hyg; 2020 Aug; 103(2):652-658. PubMed ID: 32458788
[TBL] [Abstract][Full Text] [Related]
11. [The emergence of multiple antimicrobial resistance in Vibrio cholerae isolated from gastroenteritis patients in Ceará, Brazil].
Hofer E; Quintaes BR; dos Reis EM; Rodrigues Ddos P; Seki LM; Feitosa IS; Ribeiro LH; Ferreira MR
Rev Soc Bras Med Trop; 1999; 32(2):151-6. PubMed ID: 10228365
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological differences between cholera due to multiple antibiotic resistant and multiple antibiotic sensitive Vibrio cholerae infection.
Khan MU; Shahidullah M; Barua DK; Begum T
Trans R Soc Trop Med Hyg; 1986; 80(1):60-3. PubMed ID: 3726999
[TBL] [Abstract][Full Text] [Related]
13. Emergence of tetracycline-resistant Vibrio cholerae O1 serotype Inaba, in Kolkata, India.
Roychowdhury A; Pan A; Dutta D; Mukhopadhyay AK; Ramamurthy T; Nandy RK; Bhattacharya SK; Bhattacharya MK
Jpn J Infect Dis; 2008 Mar; 61(2):128-9. PubMed ID: 18362401
[TBL] [Abstract][Full Text] [Related]
14. Class 1 integron-borne, multiple-antibiotic resistance encoded by a 150-kilobase conjugative plasmid in epidemic vibrio cholerae O1 strains isolated in Guinea-Bissau.
Dalsgaard A; Forslund A; Petersen A; Brown DJ; Dias F; Monteiro S; Molbak K; Aaby P; Rodrigues A; Sandström A
J Clin Microbiol; 2000 Oct; 38(10):3774-9. PubMed ID: 11015401
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Ciprofloxacin for Treatment of Cholera Associated with Diminished Susceptibility to Ciprofloxacin to Vibrio cholerae O1.
Khan WA; Saha D; Ahmed S; Salam MA; Bennish ML
PLoS One; 2015; 10(8):e0134921. PubMed ID: 26271050
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic and antibiogram pattern of V. cholerae isolates from a tertiary care hospital in Mumbai during 2004-2013: a retrospective cross-sectional study.
Torane V; Kuyare S; Nataraj G; Mehta P; Dutta S; Sarkar B
BMJ Open; 2016 Nov; 6(11):e012638. PubMed ID: 27888174
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in the organization of the CTX genetic element in strains of Vibrio cholerae O139 Bengal isolated from Calcutta, India and Dhaka, Bangladesh and its possible link to the dissimilar incidence of O139 cholera in the two locales.
Basu A; Mukhopadhyay AK; Sharma C; Jyot J; Gupta N; Ghosh A; Bhattacharya SK; Takeda Y; Faruque AS; Albert MJ; Balakrish Nair G
Microb Pathog; 1998 Mar; 24(3):175-83. PubMed ID: 9514639
[TBL] [Abstract][Full Text] [Related]
18. Comparative genomics of Vibrio cholerae O1 isolated from cholera patients in Bangladesh.
Hossain ZZ; Leekitcharoenphon P; Dalsgaard A; Sultana R; Begum A; Jensen PKM; Hendriksen RS
Lett Appl Microbiol; 2018 Oct; 67(4):329-336. PubMed ID: 29981154
[TBL] [Abstract][Full Text] [Related]
19. Resistance to antimicrobial agents of Vibrio cholerae E1 Tor strains isolated during the fourth cholera epidemic in the United Republic of Tanzania.
Towner KJ; Pearson NJ; Mhalu FS; O'Grady F
Bull World Health Organ; 1980; 58(5):747-51. PubMed ID: 6975183
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic Susceptibility Testing (AST) Reports: A Basis for Environmental/Epidemiological Surveillance and Infection Control Amongst Environmental
Igere BE; Okoh AI; Nwodo UU
Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32781601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
